Dashenlin (603233)
Overview
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, distributes, and retails pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and antler tonic medicinal materials, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.
Employees41141
Market Cap$18.3B
Revenue$27.5B
Listed OnShanghai Stock Exchange
Ticker603233
CEOMr. Guoqiang Ke
HeadquartersGuangzhou